Clinical Trial Update: Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on neoadjuvant or adjuvant chemotherapy in operable non-small-cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Spanish Lung Cancer Group | Conditions: Non-Small-Cell Lung Cancer | Phase 3 | Status: COMPLETED